The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there's a catch when it comes to bone health.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don’t Qualify | 0 | 6.96 | 25-08-2026 |
| 2 | 7 things to know about Medicare's new GLP-1 coverage | 0 | 7 | 02-07-2026 |
| 3 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 4 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 5 | Who qualifies for Medicare's new $50-a-month GLP-1 program? | 0 | 7.35 | 24-10-2026 |
| 6 | Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss | 0 | 12.45 | 16-06-2026 |
| 7 | How Taking a GLP-1 Could Affect Your Bone Health | 0 | 14.65 | 19-04-2026 |
| 8 | Will GLP-1s lead to fewer prescriptions for older adults? | 0 | 7 | 25-06-2026 |
| 9 | GLP-1 use hits record high as Medicare opens access to weight-loss drugs | 0 | 7 | 09-07-2026 |
| 10 | The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients | 0 | 13.02 | 24-07-2026 |